SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-011507
Filing Date
2022-03-29
Accepted
2022-03-29 08:25:45
Documents
52
Period of Report
2022-03-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10035817_8k.htm   iXBRL 8-K 34250
2 EXHIBIT 99.1 brhc10035817_ex99-1.htm EX-99.1 69548
3 EXHIBIT 99.2 brhc10035817_ex99-2.htm EX-99.2 37223
7 brhc10035817_ex99-1slide1.jpg GRAPHIC 84842
8 brhc10035817_ex99-1slide2.jpg GRAPHIC 334320
9 brhc10035817_ex99-1slide3.jpg GRAPHIC 129290
10 brhc10035817_ex99-1slide4.jpg GRAPHIC 38097
11 brhc10035817_ex99-1slide5.jpg GRAPHIC 119199
12 brhc10035817_ex99-1slide6.jpg GRAPHIC 175563
13 brhc10035817_ex99-1slide7.jpg GRAPHIC 175138
14 brhc10035817_ex99-1slide8.jpg GRAPHIC 166231
15 brhc10035817_ex99-1slide9.jpg GRAPHIC 154671
16 brhc10035817_ex99-1slide10.jpg GRAPHIC 156596
17 brhc10035817_ex99-1slide11.jpg GRAPHIC 162296
18 brhc10035817_ex99-1slide12.jpg GRAPHIC 237697
19 brhc10035817_ex99-1slide13.jpg GRAPHIC 82720
20 brhc10035817_ex99-1slide14.jpg GRAPHIC 208685
21 brhc10035817_ex99-1slide15.jpg GRAPHIC 179566
22 brhc10035817_ex99-1slide16.jpg GRAPHIC 122744
23 brhc10035817_ex99-1slide17.jpg GRAPHIC 139201
24 brhc10035817_ex99-1slide18.jpg GRAPHIC 161300
25 brhc10035817_ex99-1slide19.jpg GRAPHIC 127393
26 brhc10035817_ex99-1slide20.jpg GRAPHIC 119979
27 brhc10035817_ex99-1slide21.jpg GRAPHIC 149739
28 brhc10035817_ex99-1slide22.jpg GRAPHIC 141784
29 brhc10035817_ex99-1slide23.jpg GRAPHIC 143359
30 brhc10035817_ex99-1slide24.jpg GRAPHIC 118296
31 brhc10035817_ex99-1slide25.jpg GRAPHIC 191212
32 brhc10035817_ex99-1slide26.jpg GRAPHIC 188051
33 brhc10035817_ex99-1slide27.jpg GRAPHIC 38630
34 brhc10035817_ex99-1slide28.jpg GRAPHIC 127068
35 brhc10035817_ex99-1slide29.jpg GRAPHIC 154356
36 brhc10035817_ex99-1slide30.jpg GRAPHIC 45479
37 brhc10035817_ex99-1slide31.jpg GRAPHIC 176106
38 brhc10035817_ex99-1slide32.jpg GRAPHIC 166039
39 brhc10035817_ex99-1slide33.jpg GRAPHIC 174907
40 brhc10035817_ex99-1slide34.jpg GRAPHIC 237741
41 brhc10035817_ex99-1slide35.jpg GRAPHIC 181559
42 brhc10035817_ex99-1slide36.jpg GRAPHIC 36718
43 brhc10035817_ex99-1slide37.jpg GRAPHIC 221242
44 logo1.jpg GRAPHIC 9740
  Complete submission text file 0001140361-22-011507.txt   7990352

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ocup-20220329.xsd EX-101.SCH 3923
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20220329_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20220329_pre.xml EX-101.PRE 16042
46 EXTRACTED XBRL INSTANCE DOCUMENT brhc10035817_8k_htm.xml XML 4077
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 22777503
SIC: 2834 Pharmaceutical Preparations